- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
UCB
Market Cap: €41.8b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€219.10
7D
-2.6%
1Y
12.8%
argenx
Market Cap: €47.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€754.40
7D
0.08%
1Y
35.5%
Celyad Oncology
Market Cap: €12.1m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.27
7D
8.5%
1Y
-29.6%
Hyloris Pharmaceuticals
Market Cap: €131.6m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.64
7D
2.9%
1Y
-28.4%
Financière de Tubize
Market Cap: €8.3b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€183.70
7D
-5.0%
1Y
17.0%
Oxurion
Market Cap: €230.6k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0028
7D
7.7%
1Y
-88.6%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-16.7%